Overview
Nephros Q3 revenue grew 35% yr/yr, beating analyst expectations
Net income for Q3 increased 84% yr/yr
Company launched new PFAS filtration solution, expanding market reach
Outlook
Company did not provide specific guidance for future quarters in the statement
Result Drivers
PROGRAMMATIC SALES - Nephros attributes 51% growth in core programmatic revenue to strong reorders and new active sites
CUSTOMER INITIATIVES - Co credits strategic focus on customer-centered initiatives for improved sales performance
PFAS SOLUTION LAUNCH - Launch of new PFAS filtration solution aims to expand market reach in areas with critical water quality needs
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$4.80 mln
$3.87 mln (2 Analysts)
Q3 Gross Margin
61.00%
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the environmental services & equipment peer group is "buy"
Wall Street's median 12-month price target for Nephros Inc is $5.50, about 3.5% below its November 5 closing price of $5.69
The stock recently traded at 103 times the next 12-month earnings vs. a P/E of 449 three months ago
Press Release: ID:nGNX4gDGlF
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
